CareDx [CDNA] vs Thermo Fisher [TMO] Detailed Stock Comparison

CareDx Inc.

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: CareDx Inc. wins in 5 metrics, Thermo Fisher Scientific Inc. wins in 13 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric CareDx Inc. Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) 13.98 25.84 CareDx Inc.
Price-to-Book Ratio 3.37 3.31 Thermo Fisher Scientific Inc.
Debt-to-Equity Ratio 8.64 82.91 CareDx Inc.
PEG Ratio -0.13 2.29 Thermo Fisher Scientific Inc.
EV/EBITDA -112.43 19.02 Thermo Fisher Scientific Inc.
Profit Margin (TTM) -5.62% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) -3.49% 17.89% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) N/A 17.89% N/A
Return on Equity -6.27% 13.52% Thermo Fisher Scientific Inc.
Return on Assets (TTM) -3.15% 5.00% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $35.44M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return 34.31% 22.27% CareDx Inc.
Price-to-Sales Ratio (TTM) 2.71 3.86 CareDx Inc.
Enterprise Value $876.39M $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 2.31 4.75 CareDx Inc.
Gross Profit Margin (TTM) 67.24% N/A N/A
Revenue per Share (TTM) $7 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $-0.40 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 2.54 0.97 Thermo Fisher Scientific Inc.
Short % of Float 12.84% 1.22% Thermo Fisher Scientific Inc.

CareDx Inc. vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

CDNA
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
CareDx Inc.1.06%2.46%5.30%17.71%26.55%15.31%
Thermo Fisher Scientific Inc.-2.42%7.56%4.21%-5.21%-16.94%-18.64%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
CareDx Inc.34.31%180.69%-71.81%399.34%128.20%128.20%
Thermo Fisher Scientific Inc.22.27%-5.31%9.75%222.18%684.25%1,233.99%

Performance & Financial Health Analysis: CareDx Inc. vs Thermo Fisher Scientific Inc.

MetricCDNATMO
Market Information
Market Cap i$1.09B$174.55B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i886,6072,356,220
90 Day Avg. Volume i701,0692,071,517
Last Close$22.30$482.08
52 Week Range$10.96 - $23.24$385.46 - $643.99
% from 52W High-4.02%-25.14%
All-Time High$99.83 (Jan 18, 2021)$672.34 (Dec 27, 2021)
% from All-Time High-77.66%-28.30%
Growth Metrics
Quarterly Revenue Growth0.25%0.06%
Quarterly Earnings Growth0.25%0.10%
Financial Health
Profit Margin (TTM) i-0.06%0.15%
Operating Margin (TTM) i-0.03%0.18%
Return on Equity (TTM) i-0.06%0.14%
Debt to Equity (MRQ) i8.6482.91
Cash & Liquidity
Book Value per Share (MRQ)$5.95$141.96
Cash per Share (MRQ)$3.46$8.75
Operating Cash Flow (TTM) i$42.03M$8.29B
Levered Free Cash Flow (TTM) i$45.75M$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend iN/A$1.76

Valuation & Enterprise Metrics Analysis: CareDx Inc. vs Thermo Fisher Scientific Inc.

MetricCDNA (Apr 26, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i13.9825.84
Forward P/E i18.3717.16
PEG Ratio i-0.132.29
Price to Sales (TTM) i2.713.86
Price to Book (MRQ) i3.373.31
Market Capitalization
Market Capitalization i$1.09B$174.55B
Enterprise Value i$876.39M$214.76B
Enterprise Value Metrics
Enterprise to Revenue i2.314.75
Enterprise to EBITDA i-112.4319.02
Risk & Other Metrics
Beta i2.540.97
Book Value per Share (MRQ) i$5.95$141.96

Financial Statements Comparison: CareDx Inc. vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCDNA (2025)TMO (2025)
Revenue/Sales i379.81M44.56B
Cost of Goods Sold i123.24M26.32B
COGS % of Revenue i32.4%59.1%
Gross Profit i256.57M18.24B
Gross Margin i67.6%40.9%
Research & Development i71.43M1.40B
Operating Income (EBIT) i-25.07M8.11B
Operating Margin i-6.6%18.2%
EBITDA i1.06M11.86B
EBITDA Margin i0.3%26.6%
Pre-Tax Income i-21.08M7.31B
Pre-Tax Income % of Revenue i-5.6%16.4%
Income Tax i271,000547.00M
Income Tax % of Revenue i0.1%1.2%
Net Income (Profit) i-21.35M6.72B
Profit Margin i-5.6%15.1%

Balance Sheet & Liquidity Metrics

MetricCDNA (2025)TMO (2025)
Cash & Equivalents i65.43M9.85B
Total Current Assets i257.13M28.71B
Total Current Assets % of Revenue i67.7%64.4%
Total Current Liabilities i89.85M15.19B
Total Current Liabilities % of Revenue i23.7%34.1%
Long-Term Debt i19.68M35.85B
Long-Term Debt % of Revenue i5.2%80.5%
Total Shareholders Equity i303.10M53.54B
Retained Earnings i-735.36M59.16B
Retained Earnings % of Revenue i-193.6%132.8%
Property, Plant & Equipment i22.76M0

Cash Flow Statement Comparison

MetricCDNA (2025)TMO (2025)
Operating Cash Flow i47.02M7.82B
Operating Cash Flow % of Revenue i12.4%17.5%
Capital Expenditures iN/A-1.48B
Free Cash Flow i35.44M6.29B
FCF Margin i9.3%14.1%
Debt Repayment iN/A-3.51B
Common Stock Repurchase i-87.77M-3.00B

Short Interest & Institutional Ownership Analysis

MetricCDNATMO
Shares Short i6.42M4.54M
Short Ratio i10.412.38
Short % of Float i12.84%1.22%
Shares Outstanding i50.92M371.62M
Float Shares i49.03M371.07M
% Held by Insiders i4.37%0.17%
% Held by Institutions i101.77%95.23%
% Held by Public i-6.14%4.60%

Dividend Analysis & Yield Comparison: CareDx Inc. vs Thermo Fisher Scientific Inc.

MetricCDNATMO
Last 12-Month Dividend iN/A$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.80
Ex-Dividend DateN/AMar 13, 2026